12 studies found for:    Alzheimer's | Open Studies | United States, Utah
Show Display Options
RSS Create an RSS feed from your search for:
Alzheimer's | Open Studies | United States, Utah
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting An Efficacy and Safety Study of LY3314814 in Early Alzheimer's Disease
Condition: Alzheimer´s Disease
Interventions: Drug: LY3314814;   Drug: Placebo
2 Recruiting Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease
Conditions: Alzheimer's Disease;   Dementia
Interventions: Drug: Drug: EVP-6124;   Drug: Placebo
3 Recruiting Efficacy and Safety of MK-7622 as Adjunct Therapy in Participants With Alzheimer's Disease (MK-7622-012)
Condition: Alzheimer's Disease
Interventions: Drug: MK-7622;   Drug: Placebo;   Drug: AChEI
4 Recruiting An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
Condition: Alzheimer's Disease
Interventions: Drug: Verubecestat (Part I and Part II);   Drug: Placebo (Part I);   Drug: Verubecestat (Part II)
5 Recruiting Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease
Conditions: Alzheimer's Disease;   Dementia
Interventions: Drug: Drug: EVP-6124;   Drug: Placebo
6 Recruiting Biomarker Qualification for Risk of Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) and Safety and Efficacy Evaluation of Pioglitazone in Delaying Its Onset
Condition: Mild Cognitive Impairment Due to Alzheimer's Disease
Interventions: Drug: Pioglitazone;   Drug: Pioglitazone placebo
7 Recruiting AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext
Condition: Alzheimer's Disease
Interventions: Drug: AC-1204;   Drug: Placebo
8 Recruiting A Study of Gantenerumab in Patients With Mild Alzheimer Disease
Condition: Alzheimer Disease
Interventions: Drug: florbetapir;   Drug: gantenerumab;   Drug: placebo
9 Recruiting 221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Aducanumab (BIIB037);   Drug: Placebo
10 Recruiting SAD/MAD Study to Assess Safety, Tolerability, PK & PD of MEDI1814 in Subjects With Mild-Moderate Alzheimer's Disease
Conditions: Mild-Moderate Alzheimer's Disease;   Healthy Elderly
Interventions: Biological: MEDI1814 for IV injection;   Biological: MEDI1814 for Subcutaneous Injection;   Biological: IV Placebo;   Biological: Placebo for Subcutaneous Injection
11 Recruiting Metabolic Cerebral Imaging in Incipient Dementia (MCI-ID)
Condition: Dementia
Intervention: Procedure: FDG-PET brain scan
12 Recruiting Cognitive Training and Practice Effects in MCI
Condition: Mild Cognitive Impairment
Intervention: Behavioral: computerized cognitive exercises

Indicates status has not been verified in more than two years